Larvol Delta - MaveropepimutS-a-DPXbased-immuneeducating-therapy-shows-promising-and-durable-clinical-benefit-in-patients-with-recurrent-ovarian-cancer-a-phase-2-trial

maveropepimut-S (MVP-S) - IMV Inc

cyclophosphamide - Generic mfg.

http://www.ncbi.nlm.nih.gov/pubmed/37126016

May 1, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next